Advertisement

Topics

DxNA Company Profile

05:35 EST 19th November 2017 | BioPortfolio

DxNA's GeneSTAT diagnostic platform technology allows high complexity laboratories to conduct efficient real-time diagnostic testing in a broad range of locations. The GeneSTAT platform, with an enclosed, user-friendly format, intends to make the PCR process easy to use for a clinical site. Furthermore, testing will not be limited to developed regions like the United States, Europe and Japan, but also possible in less-developed rural and economically challenged regions. Designed with economy in mind, GeneSTAT is inherently less costly than the PCR devices typical of large clinical laboratories.


News Articles [1 Associated News Articles listed on BioPortfolio]

DxNA LLC announces 510(K) submission of GeneSTAT analyzer and GeneSTAT coccidioides assay

(The Translational Genomics Research Institute) The Valley Fever assay on the GeneSTAT System has been developed based on intellectual property exclusively licensed from the Translational Genomics Res...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

DxNA

DxNA's GeneSTAT diagnostic platform technology allows high complexity laboratories to conduct efficient real-time diagnostic testing in a broad range of locations. The GeneSTAT platform, with an enclo...

More Information about "DxNA" on BioPortfolio

We have published hundreds of DxNA news stories on BioPortfolio along with dozens of DxNA Clinical Trials and PubMed Articles about DxNA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DxNA Companies in our database. You can also find out about relevant DxNA Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record